Sector ratings Bio-Rad Laboratories, Inc.

Stocks

Market Closed - NYSE 21:00:02 14/08/2026 BST			5-day change	1st Jan Change
356.26 ^USD	-1.36%		+4.04%	+17.58%

08-07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
08-05	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
BIO-RAD LABORATORIES, INC.	9.54B	BBB	-
ABBOTT LABORATORIES	193B	BBB
MEDTRONIC PLC	116B	BBB
CENCORA, INC.	59.16B	AA
HOYA CORPORATION	55.75B	AAA
BECTON, DICKINSON AND COMPANY	49.57B	A
DEXCOM, INC.	34.52B	BBB
MEDLINE INC.	31.22B	A
WEST PHARMACEUTICAL SERVICES, INC.	24.36B	AA
TERUMO CORPORATION	24.25B	AA
STERIS PLC	23.02B	AAA	-
SARTORIUS STEDIM BIOTECH	20.34B	BBB
ZIMMER BIOMET HOLDINGS, INC.	18.99B	A
SOLVENTUM CORPORATION	14.72B	BBB
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	14.71B	A
BAXTER INTERNATIONAL INC.	13.98B	A
ALIGN TECHNOLOGY, INC.	12.52B	A
GLOBUS MEDICAL, INC.	11.54B	CCC
INSULET CORPORATION	10.16B	A
DEMANT A/S	9.5B	AA
Average	37.32B	A
Weighted average by Cap.		A